GlassScriptPhysician profile
Allison J Bloom
NPI 1811150675
$1,574.42
in general payments reported to CMS, 2019-2025
13 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $140 · 2021: $240 · 2022: $314 · 2023: $237 · 2024: $219 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $636.46 | 2021-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Ferring Pharmaceuticals INC. | $451.33 | 2019-2024 | Menopur |
| Merck Sharp & Dohme LLC | $212.07 | 2019-2021 | |
| Emd Serono, INC. | $59.30 | 2020-2022 | |
| Myovant Sciences INC. | $45.46 | 2021-2022 | |
| Abbvie INC. | $34.17 | 2021 | |
| Evofem Biosciences, INC. | $32.21 | 2022 | |
| Coopersurgical, INC. | $25.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.02 | 2021 | |
| Galen US INC | $16.74 | 2021 | |
| Baxter Healthcare | $15.27 | 2020 | |
| Medtronic, INC. | $13.50 | 2023 | Truclear |
| Sumitomo Pharma America, INC. | $13.23 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.